See what computational analyses actually reported, with provenance for every claim.Know what the science actually supports before you trust the answer.
Press Enter β΅ to search claims
Explore by Goal
"I was taught that the way of progress was neither swift nor easy."
- Marie Curie
Quick Analysis Plan
Copied
The strongest evidence-backed path to unifying multimodal data is embedding-per-modality with foundation models, then simple fusion: HONeYBEE showed clinical-text embeddings reach ~98.5% cancer-type accuracy alone while fusion (concatenation) adds only context-dependent gains on 11,428 TCGA patients .
Long Analysis Plan
Evidence First: What Multimodal Unification Actually Delivers
The clearest quantitative lesson comes from HONeYBEE, which unified five modalities (clinical text, pathology reports, radiology, WSIs, molecular profiles) for 11,428 TCGA patients across 33 cancer types. Single-modality accuracy for cancer-type classification varied enormously: clinical text 98.54%, pathology reports 78.41%, molecular 56.73%, radiology 47.78%, WSI 28.41%. Fusion improved only marginally (concatenation: 98.72%) .
For survival prediction, fusion mattered more: DeepSurv on concatenated embeddings achieved C-indices of 0.847 (BRCA) and 0.820 (BLCA), far above unimodal-fusion baselines like SurvPath (0.655/0.625) .
A known failure mode in unified latents is posterior collapse. Entropic Autoencoders counter this: on Frey Faces, VAEs used only 3/64 active latent units versus 64/64 for EAEs, while EAE test MSE was competitive (0.0052 vs 0.0046) .
Recommended Plan (Phased)
1. Harmonize: Ingest per-modality via anndata/scanpy (omics), pandas (clinical/EHR), and standard imaging pipelines; align on shared patient/sample keys, mirroring MINDS ingestion .
2. Embed: Apply modality-specific foundation models per modality; fine-tune weak encoders (pathology gains of 7.8β12.7 pp were reported).
3. Fuse: Benchmark concatenation, mean pooling, Kronecker product; note mean pooling degraded clustering (NMI 0.435 vs clinical-only 0.745) β weaker modalities dilute signal.
4. Model: Use probabilistic heads (Cox/DeepSurv, Random Forest classifiers); evaluate with 5-fold CV and held-out external cohorts (CGCI, CPTAC).
5. Handle missingness: Explicitly model incomplete modalities β real-world cohorts rarely have all five .
Known Limitations & Blind Spots
Clinical-text dominance may be a TCGA curation artifact (annotation leakage risk); external validation is essential .
EAE results rest on first-cumulant approximations and temperature-sensitive sampling; reproducibility is limited (code access incomplete) .
Building a modular multimodal unification pipeline that ingests clinical, imaging, pathology, and molecular data, generates per-modality embeddings, fuses them via concatenation, and benchmarks downstream classification and survival prediction.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
More modalities always improve predictions: HONeYBEE shows mean pooling and weak-modality fusion degraded clustering vs clinical-only embeddings.
Deeper latent spaces solve posterior collapse: Vanilla AEs use full capacity yet lack probabilistic calibration; EAEs fix collapse structurally via entropy, not capacity.
Quick Analysis Plan
Long Analysis Plan
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Ask a Follow-Up
Key Insight
